Overexpression of EGF-R and its downstream pathway are linked to epithelial–mesenchymal transition, migration, and tumor invasion [59], while NF-κB plays a key role in regulating the immune responses and promotes cancer-initiating cells [60]. Here, NFKB1 is linked to cancer.